Evan Thoman

Evan Thoman is an Engineer II on the Process Development team at GentiBio. Evan attended Washington State University (Go Cougs!) where he received his B.S. in Bioengineering. Post-graduation, he started his career working at AGC Biologics in Bothell, WA working on upstream process development of preclinical and commercial biologics. He then joined Juno Therapeutics/Celgene/BMS where he worked with the Process Characterization team to deliver late-stage process development to support the commercialization of Breyanzi and other CAR-T cell therapies. Most recently Evan has been working on early process development and process transfer of CAR-T therapies at BMS.